Harry Crijns

Professor

Harry Crijns is professor and chair of Cardiology and board member of the Cardiovascular Research Institute Maastricht (CARIM) at Maastricht UMC+. He studied medicine at the University of Amsterdam and was trained in cardiology and electrophysiology in Groningen and Maastricht. He is a Fellow of the ESC and a past board member of the EHRA. He is also past Chair of the Netherlands Society of Cardiology. He served on several guidelines committees for the management of AF. Currently he is the chairman of the scientific advisory board of the Dutch Heart Foundation.

His primary research focus continues to be atrial fibrillation (AF). He founded the RACE trials in the Netherlands and led the Euro Heart Survey on AF (ESC). He has established his reputation by introducing innovative concepts for diagnosis and treatment of AF by showing that - quite contrary to longstanding beliefs - electrical management does not change prognosis. This revolutionised management of the arrhythmia worldwide with the effect that major interventions like electrical cardioversion, catheter ablation and antiarrhythmic drug therapy are applied in a much more personalized fashion.

Subsequently his group showed that rate control in AF can be individualized thereby removing the previously used strict heart rate targets from the international guidelines. He also performed the Euro Heart Survey on AF and made many contributions to the field of stroke management in AF, such as the construction of well-recognised AF specific risk stratification scores for AF progression (HATCH), ischemic stroke (CHA2DS2-VASc) and major bleeding (HAS-BLED). These scores have practically conquered the medical AF community and improved patient care whilst boosting new clinical research throughout the world.

His research group now focusses on recent-onset AF, hybrid AF ablation, upstream therapy and vascular mechanisms for AF progression and stroke in idiopathic atrial fibrillation. He is (co-)author on over 650 scientific articles, with 56,677 citations and Hirsch-index of 100.

Department of Cardiology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht


  • 2022
    • Vaduganathan, M., Piccini, J. P., Camm, A. J., Crijns, H. J. G. M., Anker, S. D., Butler, J., Stewart, J., Braceras, R., Albuquerque, A. P. A., Wieloch, M., & Hohnloser, S. H. (2022). Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial. European journal of heart failure, 24(6), 1094-1101. https://doi.org/10.1002/ejhf.2487
    • Svennberg, E., Tjong, F., Goette, A., Akoum, N., Di Biaise, L., Bordachar, P., Boriani, G., Burri, H., Conte, G., Deharo, J.-C., Deneke, T., Drossart, I., Duncker, D., Han, J. K., Heidbuchel, H., Jais, P., de Oliviera Figueiredo, M. J., Linz, D., Lip, G. Y. H., ... Sinner, M. (2022). How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. EP Europace, 24(6), 979-1005. https://doi.org/10.1093/europace/euac038
    • Camm, A. J., Naccarelli, G. V., Mittal, S., Crijns, H. J. G. M., Hohnloser, S. H., Ma, C.-S., Natale, A., Turakhia, M. P., & Kirchhof, P. (2022). The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 79(19), 1932-1948. https://doi.org/10.1016/j.jacc.2022.03.337
    • Hermans, A. N. L., Gawalko, M., Dohmen, L., van der Velden, R. M. J., Betz, K., Duncker, D., Verhaert, D. V. M., Heidbuchel, H., Svennberg, E., Neubeck, L., Eckstein, J., Lane, D. A., Lip, G. Y. H., Crijns, H. J. G. M., Sanders, P., Hendriks, J. M., Pluymaekers, N. A. H. A., & Linz, D. (2022). Mobile health solutions for atrial fibrillation detection and management: a systematic review. Clinical research in cardiology, 111(5), 479-491. https://doi.org/10.1007/s00392-021-01941-9
    • Metzner, A., Suling, A., Brandes, A., Breithardt, G., Camm, A. J., Crijns, H. J. G. M., Eckardt, L., Elvan, A., Goette, A., Haegeli, L. M., Heidbuchel, H., Kautzner, J., Kuck, K.-H., Mont, L., Ng, A. A., Szumowski, L., Themistoclakis, S., van Gelder, I. C., Vardas, P., ... Kirchhof, P. (2022). Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial. EP Europace, 24(4), 552-564. https://doi.org/10.1093/europace/euab200
    • Meems, L. M. G., Artola Arita, V., Velt, M., Dudink, E. A. M. P., Crijns, H. J. G. M., Van Gelder, I. C., & Rienstra, M. (2022). Increased plasma levels of NT-proBNP, Troponin T and GDF-15 are driven by persistent AF and associated comorbidities: Data from the AF-RISK study. IJC Heart and Vasculature, 39, Article 100987. https://doi.org/10.1016/j.ijcha.2022.100987
    • Willems, S., Borof, K., Brandes, A., Breithardt, G., Camm, A. J., Crijns, H. J. G. M., Eckardt, L., Gessler, N., Goette, A., Haegeli, L. M., Heidbuchel, H., Kautzner, J., Ng, G. A., Schnabel, R. B., Suling, A., Szumowski, L., Themistoclakis, S., Vardas, P., van Gelder, I. C., ... Kirchhof, P. (2022). Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial. European Heart Journal, 43(12), 1219-1230. https://doi.org/10.1093/eurheartj/ehab593
    • Crijns, H. J. G. M., Sanders, P., Albert, C. M., & Lambiase, P. D. (2022). The year in cardiovascular medicine 2021: arrhythmias. European Heart Journal, 43(12), 1191-1197. https://doi.org/10.1093/eurheartj/ehac007
    • Zink, M. D., Laureanti, R., Hermans, B. J. M., Pison, L., Verheule, S., Philippens, S., Pluymaekers, N., Vroomen, M., Hermans, A., van Hunnik, A., Crijns, H. J. G. M., Vernooy, K., Linz, D., Mainardi, L., Auricchio, A., Zeemering, S., & Schotten, U. (2022). Extended ECG Improves Classification of Paroxysmal and Persistent Atrial Fibrillation Based on P- and f-Waves. Frontiers in physiology, 13, Article 779826. https://doi.org/10.3389/fphys.2022.779826
    • Koldenhof, T., Wijtvliet, P. E. P. J., Pluymaekers, N. A. H. A., Rienstra, M., Folkeringa, R. J., Bronzwaer, P., Elvan, A., Elders, J., Tukkie, R., Luermans, J. G. L. M., van Kuijk, S. M. J., Tijssen, J. G. P., van Gelder, I. C., Crijns, H. J. G. M., & Tieleman, R. G. (2022). Rate control drugs differ in the prevention of progression of atrial fibrillation. EP Europace, 24(3), 384-389. https://doi.org/10.1093/europace/euab191
    • Camaro, C., Bonnes, J. L., Adang, E. M., Spoormans, E. M., Janssens, G. N., van der Hoeven, N. W., Jewbali, L. S., Dubois, E. A., Meuwissen, M., Rijpstra, T. A., Bosker, H. A., Blans, M. J., Bleeker, G. B., Baak, R., Vlachojannis, G. J., Eikemans, B. J., van der Harst, P., van der Horst, I. C., Voskuil, M., ... van Royen, N. (2022). Cost Analysis From a Randomized Comparison of Immediate Versus Delayed Angiography After Cardiac Arrest. Journal of the American Heart Association, 11(5), Article e022238. https://doi.org/10.1161/JAHA.121.022238
    • Luyten, P., Heuts, S., Cheriex, E., Olsthoorn, J. R., Crijns, H. J. G. M., Winkens, B., Roos-Hesselink, J. W., Nia, P. S., & Schalla, S. (2022). Mitral prolapsing volume is associated with increased cardiac dimensions in patients with mitral annular disjunction. Netherlands Heart Journal, 30(3), 131-139. https://doi.org/10.1007/s12471-021-01575-6
    • Crijns, H. J. G. M., Elvan, A., Al-Windy, N., Tuininga, Y. S., Badings, E., Aksoy, I., Van Gelder, I. C., Madhavapeddi, P., Camm, A. J., Kowey, P. R., Ruskin, J. N., Belardinelli, L., & INSTANT Investigators (2022). Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm. Circulation. Arrhythmia and electrophysiology, 15(3), Article e010204. https://doi.org/10.1161/circep.121.010204
    • De With, R. R., Artola Arita, V., Nguyen, B.-O., Linz, D., Ten Cate, H., Spronk, H., Schotten, U., van Zonneveld, A. J., Erküner, Ö., Bayón, M. A., Schmidt, A. S., Luermans, J. G. L. M., Crijns, H. J. G. M., Van Gelder, I. C., & Rienstra, M. (2022). Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies. EP Europace, 24(2), 193-201. https://doi.org/10.1093/europace/euab179
    • Spoormans, E. M., Lemkes, J. S., Janssens, G. N., van der Hoeven, N. W., Jewbali, L. S. D., Dubois, E. A., Meuwissen, M., Rijpstra, T. A., Bosker, H. A., Blans, M. J., Bleeker, G. B., Baak, R., Vlachojannis, G. J., Eikemans, B. J. W., Girbes, A. R. J., van der Harst, P., van der Horst, I. C. C., Voskuil, M., van der Heijden, J. J., ... Elbers, P. W. G. (2022). Targeted Temperature Management in Out-of-Hospital Cardiac Arrest With Shockable Rhythm: A Post Hoc Analysis of the Coronary Angiography After Cardiac Arrest Trial. Critical Care Medicine, 50(2), e129-e142. https://doi.org/10.1097/CCM.0000000000005271
    • Artola Arita, V., Santema, B. T., De With, R. R., Nguyen, B.-O., Linz, D., Schotten, U., Van Gelder, I. C., Crijns, H. J., Voors, A. A., & Rienstra, M. (2022). Atrial function in paroxysmal AF patients with and without heart failure with preserved ejection fraction: Data from the AF-RISK study. American Heart Journal, 244, 36-41. https://doi.org/10.1016/j.ahj.2021.10.183
    • Thind, M., Zareba, W., Atar, D., Crijns, H. J. G. M., Zhu, J., Pak, H. N., Reiffel, J., Ludwigs, U., Wieloch, M., Stewart, J., & Kowey, P. (2022). Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials. Clinical Cardiology, 45(1), 101-109. https://doi.org/10.1002/clc.23765
    • Weerts, J., Barandiarán Aizpurua, A., Henkens, M. T. H. M., Lyon, A., van Mourik, M. J. W., van Gemert, M. R. A. A., Raafs, A., Sanders-van Wijk, S., Bayés-Genís, A., Heymans, S. R. B., Crijns, H. J. G. M., Brunner-La Rocca, H.-P., Lumens, J., van Empel, V. P. M., & Knackstedt, C. (2022). The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fraction. European Heart Journal Cardiovascular Imaging, 23(1), 74-84. https://doi.org/10.1093/ehjci/jeab222
  • 2021
    • Hermans, B. J. M., Zink, M. D., Rosmalen, F. V., Crijns, H. J. G. M., Vernooy, K., Postema, P., Pison, L., Schotten, U., & Delhaas, T. (2021). Corrected QT interval prolongation after ganglionated plexus ablation: myth or reality?-Authors' reply. EP Europace, 23(12), 2047-2048. https://doi.org/10.1093/europace/euab148
    • Bidar, E., Zeemering, S., Gilbers, M., Isaacs, A., Verheule, S., Zink, M. D., Maesen, B., Bramer, S., Kawczynski, M., Van Gelder, I. C., Crijns, H. J. G. M., Maessen, J. G., & Schotten, U. (2021). Clinical and electrophysiological predictors of device-detected new-onset atrial fibrillation during 3 years after cardiac surgery. EP Europace, 23(12), 1922-1930. https://doi.org/10.1093/europace/euab136
    • Hermans, B. J. M., Zink, M. D., Rosmalen, F. V., Crijns, H. J. G. M., Vernooy, K., Postema, P., Pison, L., Schotten, U., & Delhaas, T. (2021). Does pulmonary vein isolation prolong QT-interval?-Authors' reply. EP Europace, 23(12), 2046-2047. https://doi.org/10.1093/europace/euab153
    • Adriaans, B. P., Ramaekers, M. J. F. G., Heuts, S., Crijns, H. J. G. M., Bekkers, S. C. A. M., Westenberg, J. J. M., Lamb, H. J., Wildberger, J. E., & Schalla, S. (2021). Determining the optimal interval for imaging surveillance of ascending aortic aneurysms. Netherlands Heart Journal, 29(12), 623-631. https://doi.org/10.1007/s12471-021-01564-9
    • Kawczynski, M. J., Gilbers, M., Van de Walle, S., Schalla, S., Crijns, H. J., Maessen, J. G., Schotten, U., Maesen, B., & Bidar, E. (2021). Role of pre-operative transthoracic echocardiography in predicting post-operative atrial fibrillation after cardiac surgery: a systematic review of the literature and meta-analysis. EP Europace, 23(11), 1731-1743. https://doi.org/10.1093/europace/euab095
    • Lyon, A., van Mourik, M., Cruts, L., Heijman, J., Bekkers, S. C. A. M., Schotten, U., Crijns, H. J. G. M., Linz, D., & Lumens, J. (2021). Understanding the effects of heart beat irregularity on ventricular function in human atrial fibrillation: simulation models may help to untie the knot-Authors' reply. EP Europace, 23(11), 1869-1869. https://doi.org/10.1093/europace/euab144
    • Erkuner, O., Van Eck, M., Xhaet, O., Verheij, H., Neefs, J., Duygun, A., Nijmeijer, R., Said, S. A. M., Uiterwaal, H., Hagens, V., Bhagwandien, R., Szili-Torok, T., Bijsterveld, N., Tjeerdsma, G., Vijgen, J., Friart, A., Hoffer, E., Evrard, P., Srynger, M., ... Mairesse, G. H. (2021). Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry. Netherlands Heart Journal, 29(11), 584-594. https://doi.org/10.1007/s12471-021-01634-y
    • Mueller, P., Weijs, B., Bemelmans, N. M. A. A., Muegge, A., Eckardt, L., Crijns, H. J. G. M., Bax, J. J., Linz, D., & den Uijl, D. W. (2021). Echocardiography-derived total atrial conduction time (PA-TDI duration): risk stratification and guidance in atrial fibrillation management. Clinical research in cardiology, 110(11), 1734-1742. https://doi.org/10.1007/s00392-021-01917-9
    • Hermans, A. N. L., Pluymaekers, N. A. H. A., Lankveld, T. A. R., van Mourik, M. J. W., Zeemering, S., Dinh, T., den Uijl, D. W., Luermans, J. G. L. M., Vernooy, K., Crijns, H. J. G. M., Schotten, U., & Linz, D. (2021). Clinical utility of rhythm control by electrical cardioversion to assess the association between self-reported symptoms and rhythm status in patients with persistent atrial fibrillation. IJC Heart and Vasculature, 36, Article 100870. https://doi.org/10.1016/j.ijcha.2021.100870
    • Dural, M., van Stipdonk, A. M. W., Salden, F. C. W. M., Ter Horst, I., Crijns, H. J. G. M., Meine, M., Maass, A. H., Kloosterman, M., & Vernooy, K. (2021). Association of ECG characteristics with clinical and echocardiographic outcome to CRT in a non-LBBB patient population. Journal of Interventional Cardiac Electrophysiology, 62(1), 9-19. https://doi.org/10.1007/s10840-020-00866-z
    • Van Der Velden, R. M. J., Verhaert, D. V. M., Hermans, A. N. L., Duncker, D., Manninger, M., Betz, K., Gawalko, M., Desteghe, L., Pisters, R., Hemels, M., Pison, L., Sohaib, A., Sultan, A., Steven, D., Wijtvliet, P., Gupta, D., Svennberg, E., Luermans, J. C. L. M., Chaldoupi, M., ... Linz, D. (2021). The photoplethysmography dictionary: practical guidance on signal interpretation and clinical scenarios from TeleCheck-AF. European Heart Journal - Digital Health, 2(3), 363-373. https://doi.org/10.1093/ehjdh/ztab050
    • Rillig, A., Magnussen, C., Ozga, A. K., Suling, A., Brandes, A., Breithardt, G., Camm, A. J., Crijns, H. J. G. M., Eckardt, L., Elvan, A., Goette, A., Gulizia, M., Haegeli, L., Heidbuchel, H., Kuck, K. H., Ng, A., Szumowski, L., van Gelder, I., Wegscheider, K., & Kirchhof, P. (2021). Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure. Circulation, 144(11), 845-858. https://doi.org/10.1161/CIRCULATIONAHA.121.056323
    • Crijns, H. J. G. M., & Vernooy, K. (2021). To drive or NOT to drive: that's the question after ICD implantation. European Heart Journal, 42(35), 3538-3540. https://doi.org/10.1093/eurheartj/ehab490
    • Al-Jazairi, M. I. H., Nguyen, B. O., De With, R. R., Smit, M. D., Weijs, B., Hobbelt, A. H., Alings, M., Tijssen, J. G. P., Geelhoed, B., Hillege, H. L., Tieleman, R. G., Van Veldhuisen, D. J., Crijns, H. J. G. M., Van Gelder, I. C., Blaauw, Y., Rienstra, M., & RACE 3 Investigators (2021). Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study. EP Europace, 23(9), 1359-1368. https://doi.org/10.1093/europace/euab062
    • van Gorp, R. H., Baaten, C. C. F. M. J., Habibi, A., Jaminon, A. M. G., Peeters, F. E. C. M., Leenders, P., Crijns, H. J. G. M. C., Heemskerk, J. W. M., Reutelingsperger, C. P., Spronk, H. M., & Schurgers, L. J. (2021). Vitamin K antagonist use induces calcification and atherosclerotic plaque progression resulting in increased hypercoagulability. European heart journal open, 1(2), Article oeab017. https://doi.org/10.1093/ehjopen/oeab017
    • Lisan, Q., van Sloten, T., Boutouyrie, P., Laurent, S., Danchin, N., Thomas, F., Guibout, C., Perier, M.-C., Dagnelie, P., Henry, R. M., Schram, M. T., Heinzer, R., Marques-Vidal, P., van der Kallen, C. J., Crijns, H. J., van Greevenbroek, M., Reesink, K., Köhler, S., Sastry, M., ... Empana, J.-P. (2021). Sleep Apnea is Associated With Accelerated Vascular Aging: Results From 2 European Community-Based Cohort Studies. Journal of the American Heart Association, 10(15), Article 021318. https://doi.org/10.1161/JAHA.120.021318
    • Nia, P. S., Olsthoorn, J. R., Heuts, S., van Kuijk, S. M. J., Vainer, J., Streukens, S., Schalla, S., Segers, P., Barenbrug, P., Crijns, H. J. G. M., & Maessen, J. G. (2021). Effect of a dedicated mitral heart team compared to a general heart team on survival: a retrospective, comparative, non-randomized interventional cohort study based on prospectively registered data. European Journal of Cardio-Thoracic Surgery, 60(2), 263-273. https://doi.org/10.1093/ejcts/ezab065
    • Nedios, S., Lindemann, F., Heijman, J., Crijns, H. J. G. M., Bollmann, A., & Hindricks, G. (2021). Atrial remodeling and atrial fibrillation recurrence after catheter ablation: Past, present, and future developments. Herz, 46(4), 312-317. https://doi.org/10.1007/s00059-021-05050-1
    • Crijns, H., Sanders, P., & Lambiase, P. (2021). Arrhythmias in the European Heart Journal. European Heart Journal, 42(26), 2524-2524. Article ehab229. https://doi.org/10.1093/eurheartj/ehab229
    • de Vries, T. A. C., Hemels, M. E. W., Cools, F., Crijns, H. J. G. M., Yperzeele, L., Vanacker, P., Blankoff, I., Lancellotti, P., Mairesse, G. H., de Veer, A., Casado Arroyo, R., Catez, E., de Pauw, M., Vanassche, T., de Asmundis, C., Kirchhof, P., De Caterina, R., de Groot, J. R., & ETNA-AF-Europe principal investigators from Belgium and the Netherlands (2021). Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study. Acta Cardiologica, 76(4), 431-439. https://doi.org/10.1080/00015385.2020.1746095
    • Vroomen, M., van Rosmalen, F., Schroeder, J., Philippens, S., Delhaas, T., Crijns, H. J., & Pison, L. (2021). Ten-year follow-up after endocardial point-by-point cryoablation for paroxysmal atrial fibrillation. Acta Cardiologica, 76(4), 425-430. https://doi.org/10.1080/00015385.2020.1756087
    • Potpara, T. S., Lip, G. Y. H., Dagres, N., Crijns, H. J. M. G., Boriani, G., Kirchhof, P., Arbelo, E., Savelieva, I., Lenarczyk, R., Fauchier, L., Maggioni, A. P., Gale, C. P., & EORP-AF III Investigators Group (2021). Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry. European heart journal - Quality of care & clinical outcomes, 7(3), 229-237. https://doi.org/10.1093/ehjqcco/qcaa050
    • Lemkes, J. S., Spoormans, E. M., Demirkiran, A., Leutscher, S., Janssens, G. N., van der Hoeven, N. W., Jewbali, L. S. D., Dubois, E. A., Meuwissen, M., Rijpstra, T. A., Bosker, H. A., Blans, M. J., Bleeker, G. B., Baak, R., Vlachojannis, G. J., Eikemans, B. J. W., van der Harst, P., van der Horst, I. C. C., Voskuil, M., ... van Royen, N. (2021). The effect of immediate coronary angiography after cardiac arrest without ST-segment elevation on left ventricular function. A sub-study of the COACT randomised trial. Resuscitation, 164, 93-100. https://doi.org/10.1016/j.resuscitation.2021.04.020
    • Gawalko, M., Duncker, D., Manninger, M., van der Velden, R. M. J., Hermans, A. N. L., Verhaert, D. V. M., Pison, L., Pisters, R., Hemels, M., Sultan, A., Steven, D., Gupta, D., Heidbuchel, H., Sohaib, A., Wijtvliet, P., Tieleman, R., Gruwez, H., Chun, J. L., Schmidt, B., ... TeleCheck-AF investigators (2021). The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: centre and patient experiences. EP Europace, 23(7), 1003-1015. https://doi.org/10.1093/europace/euab050
    • Crijns, H. J. G. M., Prinzen, F., Lambiase, P. D., Sanders, P., & Brugada, J. (2021). The year in cardiovascular medicine 2020: arrhythmias. Cardiologia Hungarica, 51(3), 164-170. https://doi.org/0.1093/eurheartj/ehaa1091
    • Heijman, J., Sutanto, H., Crijns, H. J. G. M., Nattel, S., & Trayanova, N. A. (2021). Computational models of atrial fibrillation: achievements, challenges and perspectives for improving clinical care. Cardiovascular Research, 117(7), 1682-1699. https://doi.org/10.1093/cvr/cvab138
    • Nguyen, B. O., Meems, L. M. G., van Faassen, M., Crijns, H. J. G. M., van Gelder, I. C., Kuipers, F., & Rienstra, M. (2021). Gut-microbe derived TMAO and its association with more progressed forms of AF: Results from the AF-RISK study. IJC Heart & Vasculature, 34, Article 100798. https://doi.org/10.1016/j.ijcha.2021.100798
    • Dudink, E. A. M. P., Bidar, E., Jacobs, J., van Hunnik, A., Zeemering, S., Weijs, B., Luermans, J. G. L. M., Maesen, B. A. E., Cheriex, E. C., Maessen, J. G., Hoorntje, J. C. A., Schotten, U., Crijns, H. J. G. M., & Verheule, S. (2021). The relation between the atrial blood supply and the complexity of acute atrial fibrillation. IJC Heart & Vasculature, 34, Article 100794. https://doi.org/10.1016/j.ijcha.2021.100794
    • Crijns, H. J. G. M., Prinzen, F., Lambiase, P. D., Sanders, P., & Brugada, J. (2021). The year in cardiovascular medicine 2020: arrhythmias. Cor et Vasa, 63, 6-14. https://www.e-coretvasa.cz/en/artkey/cor-202188-0002_the-year-in-cardiovascular-medicine-2020-arrhythmias.php?l=en
    • Pluymaekers, N. A. H. A., Dudink, E. A. M. P., Weijs, B., Vernooy, K., Hartgerink, D. E. J., Jacobs, J. S., Erkuner, O., Marcks, N. G. H. M., van Cauteren, Y. J. M., Dinh, T., ter Bekke, R. M. A., Sels, J. E. M. W., Delnoij, T. S. R., Geyik, Z., Driessen, R. G. H., Linz, D. K., den Uijl, D. W., Crijns, H. J. G. M., & Luermans, J. G. L. M. (2021). Clinical determinants of early spontaneous conversion to sinus rhythm in patients with atrial fibrillation. Netherlands Heart Journal, 29(5), 255-261. https://doi.org/10.1007/s12471-020-01528-5